News
By sharing early-stage tools and data openly, life sciences companies can minimize duplication and de-risk R&D without ...
What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...
Polymorphs, or different crystalline forms of the same drug, can be selected for distinct properties and patented. A recent court ruling, however, adds new complexity, write experts at Finnegan.
A key focus of Part III in this clinical trial payment series is the tax implications of trial payments. This article emphasizes that while reimbursements for out-of-pocket expenses are tax-exempt and ...
On this weeks Business of Biotech, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet ...
More than half of drug launches fall short of forecasts. Engaging payers during trial design and capturing outcomes with real ...
We asked John Oyler, an American entrepreneur and the chairman, cofounder, and CEO of BeiGene, why he decided to build a global biopharmaceutical company with roots beginning in China. His answer may ...
Chris Anzalone, CEO of Arrowhead Pharmaceuticals, discusses overcoming adversity while leading the company through challenging times.
Matt Patterson, chairman and CEO of Audentes Therapeutics, shares the experiences that prepared him for building the gene therapy company he cofounded into a publicly traded business valued at nearly ...
Experts at Faegre Drinker offer life sciences business planning and risk mitigation strategies to consider in response to enacted or anticipated policy changes under the Trump administration.
Is the bloom off the rose when it comes to investing in digital technology in the life sciences sector? It’s not, but it might not be blooming as fast as originally thought.
Sponsors need to proactively identify and manage the risks involved with working with a CRO. This kind of oversight can help reduce the likelihood of negative consequences that could impact the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results